(0.01%) 5 207.00 points
(0.05%) 39 016 points
(-0.17%) 18 165 points
(-0.27%) $78.27
(1.23%) $2.22
(-0.29%) $2 324.40
(-0.32%) $27.53
(0.05%) $965.35
(0.07%) $0.929
(0.39%) $10.87
(0.17%) $0.797
(-0.12%) $91.23
2 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 13.43%
5.13% $ 4.92
Live Chart Being Loaded With Signals
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 23 128.00 |
Średni wolumen | 67 813.00 |
Kapitalizacja rynkowa | 26.15M |
EPS | $0 ( 2024-03-08 ) |
Następna data zysków | ( $-0.680 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.570 |
ATR14 | $0.0690 (1.36%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-08 | Patel Mahesh V. | Buy | 4 893 | Common Stock |
2024-03-08 | Fogarty Krista | Buy | 991 | Common Stock |
2023-05-25 | Patel Mahesh V. | Buy | 8 706 | Common Stock |
2023-05-10 | Papapetropoulos Spyros | Buy | 30 000 | Stock Option (Right to Buy) |
2023-05-10 | Higuchi John W. | Buy | 30 000 | Common Stock (Right to Buy) |
INSIDER POWER |
---|
93.74 |
Last 96 transactions |
Buy: 4 769 643 | Sell: 1 163 369 |
Wolumen Korelacja
Lipocine Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SRTS | 0.946 |
CNDT | 0.935 |
TBNK | 0.928 |
SWVL | 0.926 |
VNET | 0.916 |
VTRS | 0.915 |
KOD | 0.915 |
RUBY | 0.915 |
ATHA | 0.914 |
GTEC | 0.912 |
10 Najbardziej negatywne korelacje | |
---|---|
TYHT | -0.92 |
CNCE | -0.913 |
ZSAN | -0.906 |
EPZM | -0.897 |
VERX | -0.886 |
ORPH | -0.885 |
BIVI | -0.884 |
PLW | -0.883 |
XOG | -0.883 |
BGFV | -0.881 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lipocine Inc Korelacja - Waluta/Towar
Lipocine Inc Finanse
Annual | 2023 |
Przychody: | $109 987 |
Zysk brutto: | $81 326.00 (73.94 %) |
EPS: | $-3.10 |
FY | 2023 |
Przychody: | $109 987 |
Zysk brutto: | $81 326.00 (73.94 %) |
EPS: | $-3.10 |
FY | 2022 |
Przychody: | $500 000 |
Zysk brutto: | $-8.06M (-1 611.38 %) |
EPS: | $-2.07 |
FY | 2021 |
Przychody: | $16 141.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.0000073 |
Financial Reports:
No articles found.
Lipocine Inc
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis; LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the management of decompensated cirrhosis; LPCN 1154, an investigational new drug application to conduct a Phase 2 study in Postpartum depression; LPCN 2101 for women with epilepsy, which has completed pre-clinical study; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej